blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3093023

EP3093023 - PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT [Right-click to bookmark this link]
Former [2016/46]PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PHARMACEUTICAL PREPARATION FOR CANCER TREATMENT CONTAINING SAME COMPOSITION AS ACTIVE INGREDIENT
[2020/25]
StatusNo opposition filed within time limit
Status updated on  10.09.2021
Database last updated on 28.06.2024
FormerThe patent has been granted
Status updated on  02.10.2020
FormerGrant of patent is intended
Status updated on  03.06.2020
FormerExamination is in progress
Status updated on  16.03.2018
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
QUARRYMEN & CO. INC.
14-23, Seijo 6-chome
Setagaya-ku
Tokyo 157-0066 / JP
[2017/04]
Former [2016/46]For all designated states
Quarrymen Corporation
14-23, Seijo 6-chome
Setagaya-ku
Tokyo, 1570066 / JP
Inventor(s)01 / UEDA, Minoru
61, Akiya, 4540-banchi
Yokosuka-shi
Kanagawa 240-0105 / JP
 [2016/52]
Former [2016/46]01 / UEDA, Minoru
7-9 Denenchofu 3-chome
Ohta-ku
Tokyo 145-0071 / JP
Representative(s)Prüfer & Partner mbB Patentanwälte · Rechtsanwälte
Sohnckestraße 12
81479 München / DE
[2016/46]
Application number, filing date15740157.123.01.2015
[2016/46]
WO2015JP51887
Priority number, dateJP2014001172924.01.2014         Original published format: JP 2014011729
[2016/46]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015111712
Date:30.07.2015
Language:JA
[2015/30]
Type: A1 Application with search report 
No.:EP3093023
Date:16.11.2016
Language:EN
[2016/46]
Type: B1 Patent specification 
No.:EP3093023
Date:04.11.2020
Language:EN
[2020/45]
Search report(s)International search report - published on:JP30.07.2015
(Supplementary) European search report - dispatched on:EP08.09.2017
ClassificationIPC:C12N5/074, A61K35/32
[2020/25]
CPC:
A61K38/30 (EP,KR,US); A61K35/12 (EP,KR,US); A61K38/1841 (EP,US);
A61K38/1866 (EP,KR,US); A61K38/195 (EP,US); A61P35/00 (EP);
C12N5/0664 (US); C12N5/0696 (EP,KR,US); A61K35/32 (US);
C12N2500/02 (EP,KR,US); C12N2500/90 (US); C12N2500/99 (EP,US);
C12N2501/105 (EP,KR,US); C12N2501/15 (US); C12N2501/165 (EP,KR,US);
C12N2501/21 (US); C12N2501/60 (EP,KR,US); C12N2501/998 (EP,KR,US);
C12N2506/1361 (EP,KR,US); C12N2510/04 (US) (-)
Former IPC [2017/41]A61K35/32, A61P35/00, A61K38/30, A61K38/19, A61K38/18
Former IPC [2016/46]A61K35/32, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/46]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR KREBSBEHANDLUNG[2020/25]
English:PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT[2020/25]
French:COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DU CANCER[2020/25]
Former [2016/46]PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR KREBSBEHANDLUNG UND PHARMAZEUTISCHE ZUBEREITUNG ZUR KREBSBEHANDLUNG MIT DIESER ZUSAMMENSETZUNG ALS WIRKSTOFF
Former [2016/46]PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PHARMACEUTICAL PREPARATION FOR CANCER TREATMENT CONTAINING SAME COMPOSITION AS ACTIVE INGREDIENT
Former [2016/46]COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DU CANCER ET PRÉPARATION PHARMACEUTIQUE POUR LE TRAITEMENT DU CANCER CONTENANT LADITE COMPOSITION EN TANT QUE SUBSTANCE ACTIVE
Entry into regional phase28.07.2016Translation filed 
28.07.2016National basic fee paid 
28.07.2016Search fee paid 
28.07.2016Designation fee(s) paid 
28.07.2016Examination fee paid 
Examination procedure28.07.2016Examination requested  [2016/46]
18.01.2018Amendment by applicant (claims and/or description)
16.03.2018Despatch of a communication from the examining division (Time limit: M04)
08.06.2018Reply to a communication from the examining division
10.04.2019Despatch of a communication from the examining division (Time limit: M06)
12.09.2019Reply to a communication from the examining division
16.12.2019Despatch of a communication from the examining division (Time limit: M04)
03.04.2020Reply to a communication from the examining division
04.06.2020Communication of intention to grant the patent
28.09.2020Fee for grant paid
28.09.2020Fee for publishing/printing paid
28.09.2020Receipt of the translation of the claim(s)
Opposition(s)05.08.2021No opposition filed within time limit [2021/41]
Fees paidRenewal fee
27.01.2017Renewal fee patent year 03
29.01.2018Renewal fee patent year 04
30.01.2019Renewal fee patent year 05
29.01.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.01.2015
AL04.11.2020
AT04.11.2020
CY04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
MK04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
IE23.01.2021
LU23.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
[2024/22]
Former [2023/30]HU23.01.2015
AL04.11.2020
AT04.11.2020
CY04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
IE23.01.2021
LU23.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2023/27]HU23.01.2015
AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
IE23.01.2021
LU23.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2022/34]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
IE23.01.2021
LU23.01.2021
BE31.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2022/23]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
IE23.01.2021
LU23.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2022/10]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
IE23.01.2021
LU23.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
PT04.03.2021
Former [2022/07]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
IE23.01.2021
LU23.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/52]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
LU23.01.2021
CH31.01.2021
LI31.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/50]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SI04.11.2020
SK04.11.2020
SM04.11.2020
LU23.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/48]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
IT04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
LU23.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/46]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
NL04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
LU23.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/45]AL04.11.2020
AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
LU23.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/43]AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
LU23.01.2021
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/40]AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
MC04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/37]AT04.11.2020
CZ04.11.2020
DK04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/36]AT04.11.2020
CZ04.11.2020
EE04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/35]AT04.11.2020
CZ04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
PL04.11.2020
RO04.11.2020
RS04.11.2020
SE04.11.2020
SK04.11.2020
SM04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/34]AT04.11.2020
CZ04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
PL04.11.2020
RS04.11.2020
SE04.11.2020
SM04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/33]AT04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LT04.11.2020
LV04.11.2020
PL04.11.2020
RS04.11.2020
SE04.11.2020
SM04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/32]AT04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LV04.11.2020
PL04.11.2020
RS04.11.2020
SE04.11.2020
SM04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/28]AT04.11.2020
ES04.11.2020
FI04.11.2020
HR04.11.2020
LV04.11.2020
PL04.11.2020
RS04.11.2020
SE04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/25]AT04.11.2020
ES04.11.2020
FI04.11.2020
LV04.11.2020
PL04.11.2020
RS04.11.2020
SE04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
IS04.03.2021
PT04.03.2021
Former [2021/23]AT04.11.2020
FI04.11.2020
LV04.11.2020
RS04.11.2020
SE04.11.2020
BG04.02.2021
NO04.02.2021
GR05.02.2021
PT04.03.2021
Former [2021/22]FI04.11.2020
RS04.11.2020
NO04.02.2021
PT04.03.2021
Former [2021/21]FI04.11.2020
PT04.03.2021
Former [2021/20]FI04.11.2020
Documents cited:Search[Y]EP2307539  (UNIV KYOTO [JP]) [Y] 1-9 * the whole document *;
 [E]EP2832851  (QUARRYMEN CORP [JP]) [E] 1-9 * the whole document *;
 [Y]  - ARANHA A M F ET AL, "Hypoxia Enhances the Angiogenic Potential of Human Dental Pulp Cells", JOURNAL OF ENDODONTICS, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, PA, US, vol. 36, no. 10, ISSN 0099-2399, (20101001), pages 1633 - 1637, (20100715), XP027290274 [Y] 1-9 * the whole document *
 [A]  - LI ET AL, "Effects of hypoxia on proliferation and differentiation of myoblasts", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH, US, (20070713), vol. 69, no. 3, ISSN 0306-9877, pages 629 - 636, XP022140498 [A] 1-9 * the whole document *
 [A]  - YING WANG ET AL, "The hypoxia-inducible factor [alpha] pathway couples angiogenesis to osteogenesis during skeletal development", JOURNAL OF CLINICAL INVESTIGATION, US, (20070601), vol. 117, no. 6, doi:10.1172/JCI31581, ISSN 0021-9738, pages 1616 - 1626, XP055401850 [A] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1172/JCI31581
 [T]  - MASAHITO FUJIO ET AL, "Conditioned media from hypoxic-cultured human dental pulp cells promotes bone healing during distraction osteogenesis : Hypoxic culture condition increases the angiogenic factors from hDPCs", JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, US, (20170701), vol. 11, no. 7, doi:10.1002/term.2109, ISSN 1932-6254, pages 2116 - 2126, XP055401803

DOI:   http://dx.doi.org/10.1002/term.2109
International search[A]JP2011529329  (KYOTO UNIVERSITY);
 [A]JP2013018756  (UNIV SAPPORO MEDICAL);
 [A]WO2013147082  (QUARRYMEN CORP [JP]);
 [A]  - TOMOKAZU HASEGAWA, "Investigation of New Strategy for Periodontal Tissue Regeneration Using with Human Immortalized Periodontal Ligament Cell Line Derived from Deciduous Teeth", THE JAPANESE JOURNAL OF PEDODONTICS, (2012), vol. 50, no. 1, pages 7 - 14, XP055357362
ExaminationEP2554175
by applicantWO2011118795
    - YUE WANG ET AL., PLOS ONE, (201301), vol. 8, no. 1, page E54296
    - M. CELESTE SIMON; BRIAN KEITH, NATURE REVIEWS/ MOLECULAR CELL BIOLOGY, (200804), vol. 9, pages 285 - 296
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.